Value, Access, and Incentives for Innovation: Policy Perspectives on Alternative Models for Pharmaceutical Rebates
![Value, Access, and Incentives for Innovation - Policy Perspectives on Alternative Models for Pharmaceutical Rebates](https://www.ohe.org/wp-content/uploads/2019/03/Value-Access-and-Incentives-for-Innovation-Policy-Perspectives-on-Alternative-Models-for-Pharmaceutical-Rebates.jpg)
Efficient decisions about allocating health care budgets require assessment of the effects of health care interventions and the value for money they provide. Decision-making processes leading to funding decisions should be structured and evidence-based.